BioMarin Pharmaceutical Inc.

(BMRN)

By |

Profile

Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.

Contact Information

Website: www.bmrn.com
Main Phone: +1 415 506-6700
Address: 770 Lindaro Street
State: CA
City / Town: San Rafael
Country: USA
Postal Code: 94901

Issuer Information

Exchange: NGS
Employees: 2158
NAICS: Pharmaceutical P
$ 82.21 ($ 1.12) (-1.34%)
Last Price 82.21 Change $ -1.12 Change % -1.34 Tick N/A
Bid 80.00 Bid Size 100.00 Ask 85.15 Ask Size 100.00
Open 83.39 High 84.02 Low 81.89 Prev Close 83.33
Last Trade Volume 1.1 mi 52 Wk Hi 107.56 52 Wk Low 62.12
Market Cap 14.1 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 171,987,437.00 EPS (TTM) -2.96 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 59 186
Number of Buys 27 86
Number of Sells 32 100
Net Activity -120421 385042
Last 10 Buys Shares
Robert A. Baffi 1,000
Mark Wood 1,000
Brian Mueller 1,000
Jean-Jacques Bienaime 1,000
Steve Aselage 1,000
Jeffrey H. Cooper 1,000
Jean-Jacques Bienaime 1,000
Richard A. Meier 1,000
Richard A. Meier 1,000
Last 10 Sell Shares
Jean-Jacques Bienaime 1,000
Daniel K. Spiegelman 1,000
G. Eric Davis 1,000
Brian Mueller 1,000
V. Bryan Lawlis 1,000
V. Bryan Lawlis 1,000
Jean-Jacques Bienaime 1,000
G. Eric Davis 1,000
V. Bryan Lawlis 1,000
Jean-Jacques Bienaime 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 150 150 150 150
Low Target Price Estimate 99 99 99 99
Mean Target Price Estimate 119.57 120.07 113.93 118.64
Standard Deviation 11.57 11.31 12.35 12.04
Date of Most Recent Estimate 08/12/16 08/05/16 07/28/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 11 12 12 12
Moderate Buy 2 2 2 2
Hold 1 1 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.29 1.27 1.38 1.38